Maxigen Financial Statements From 2010 to 2024
| 1783 Stock | TWD 43.70 0.50 1.13% |
Check Maxigen Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maxigen Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Maxigen financial statements analysis is a perfect complement when working with Maxigen Biotech Valuation or Volatility modules.
Maxigen |
Maxigen Biotech Company Current Valuation Analysis
Maxigen Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Maxigen Biotech Current Valuation | 3.32 B |
Most of Maxigen Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maxigen Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Maxigen Biotech has a Current Valuation of 3.32 B. This is 76.87% lower than that of the Healthcare sector and 98.17% lower than that of the Drug Manufacturers - Major industry. The current valuation for all Taiwan stocks is 80.02% higher than that of the company.
Maxigen Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Maxigen Biotech's current stock value. Our valuation model uses many indicators to compare Maxigen Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Maxigen Biotech competition to find correlations between indicators driving Maxigen Biotech's intrinsic value. More Info.Maxigen Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Maxigen Biotech is roughly 2.04 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Maxigen Biotech's earnings, one of the primary drivers of an investment's value.About Maxigen Biotech Financial Statements
Maxigen Biotech investors use historical fundamental indicators, such as Maxigen Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Maxigen Biotech. Please read more on our technical analysis and fundamental analysis pages.
Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and cosmeceutical skincare products in Taiwan and internationally. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan, Taiwan. MAXIGEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.